Scollr summary
What this paper is about
It is shown that certain epithelial carcinomas co-opt the death-receptor ligand Apo2L/TRAIL to suppress apoptosis while acquiring killing capacity, a surprising apoptotic "cloak-and-dagger" mechanism with significant therapeutic potential.
Full abstract
Read the full abstract
Abstract Cancer cells avert apoptosis to sustain growth, evade immunity, and resist therapy. However, how they escape specific extrinsic death signals remains unclear. We show that certain epithelial carcinomas co-opt the death-receptor ligand Apo2L/TRAIL to suppress apoptosis while acquiring killing capacity. Analysis of CRISPR knockout screens from the Cancer Dependency Map uniquely identified TRAIL as an essential tumor necrosis factor superfamily member in epithelial malignancies. Renal cell carcinomas (RCC) and squamous cell carcinomas (SCC) expressed TRAIL within both malignant and nonmalignant compartments. In RCC, loss of the tumor suppressor VHL induced HIF2α-dependent TRAIL transcription, whereas in SCC, 3q26 amplification increased TRAIL abundance. Fractional TRAIL silencing revealed killing of TRAIL-deficient cells by TRAIL-expressing counterparts, while full silencing sensitized cells to extrinsic TRAIL. Mechanistically, endogenous TRAIL suppressed apoptosis through lysosomal degradation of its cognate death receptors. Thus, cancer cells can repurpose TRAIL via a surprising apoptotic “cloak-and-dagger” mechanism with significant therapeutic potential.
Direct answer
What can I do from this paper page?
Use this page to scan "Epithelial cancer cells co-opt the death ligand TRAIL to avert extrinsic apoptosis while acquiring killing capacity" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Cell death mechanisms and regulation research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Canty2026Epithelial,
title = {Epithelial cancer cells co-opt the death ligand TRAIL to avert extrinsic apoptosis while acquiring killing capacity},
author = {John Canty and S A Marsters and David Lawrence and Serena Lee and Hartmut Koeppen and Avi Ashkenazi},
journal = {Cell Death and Differentiation},
year = {2026},
doi = {10.1038/s41418-026-01798-3},
url = {https://doi.org/10.1038/s41418-026-01798-3}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Cell death mechanisms and regulation research papers?
Follow Cell death mechanisms and regulation research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Epithelial cancer cells co-opt the death ligand TRAIL to avert extrinsic apoptosis while acquiring killing capacity. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app